IMFALDA Trademark

Trademark Overview

On Wednesday, June 28, 2017, a trademark application was filed for IMFALDA with the United States Patent and Trademark Office. The USPTO has given the IMFALDA trademark a serial number of 79214405. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 30, 2024. This trademark is owned by Dr. Falk Pharma GmbH. The IMFALDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract
imfalda

General Information

Serial Number79214405
Word MarkIMFALDA
Filing DateWednesday, June 28, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 30, 2024
Registration Number5398779
Registration DateTuesday, February 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDr. Falk Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameDr. Falk Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameDr. Falk Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, September 12, 2017ASSIGNED TO EXAMINER
Thursday, August 17, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 22, 2017APPLICATION FILING RECEIPT MAILED
Saturday, September 16, 2017NON-FINAL ACTION WRITTEN
Sunday, September 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 21, 2017REFUSAL PROCESSED BY MPU
Thursday, September 21, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 7, 2017REFUSAL PROCESSED BY IB
Tuesday, October 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018REGISTERED-PRINCIPAL REGISTER
Sunday, May 13, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, May 19, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 11, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 24, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 13, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 30, 2024CANCELLED SECTION 71
Saturday, June 23, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, December 9, 2017NOTIFICATION PROCESSED BY IB
Saturday, May 19, 2018FINAL DISPOSITION PROCESSED

Related Keywords

imfalda gastrointestinal tract upper inflammation preparations treatment pharmaceutical